Nicolai Tangen
AKO Capital
Nicolai Tangen CME Group Inc stake
total: 72
AKO Capital CME trades
- Total transactions:
- 12
- New positions:
- 1
- Sold out:
- 1
- Added:
- 8
- Reduced:
- 2
- Held since:
- 2017 Q4
- Held for:
- 11 quarters
- Latest activity:
- 2020 Q3
According to 2026 Q2 report, Nicolai Tangen doesn't hold any CME Group Inc (CME) shares. To date, the estimated cost basis is nearly $171.41 for "buy" trades and estimated average "sell" price is $173.97. AKO Capital first purchased CME in 2017 Q4, initially acquiring 291,077 shares. Since the initial investment in CME Group Inc (CME), AKO Capital has made 11 more transactions.
When did Nicolai Tangen sell CME Group Inc (CME)?
Nicolai Tangen sold off the entire CME Group Inc (CME) position in 2020 Q3.
When did Nicolai Tangen buy CME Group Inc (CME)?
Nicolai Tangen first invested in CME Group Inc (CME) in 2017 Q4 at the reported quarter-end price of $146.05 per share.
What's the cost basis of AKO Capital's CME stake?
The estimated cost basis for CME Group Inc (CME) stake is around $171.41 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $171.41
- Weighted AVG sell price:
- $173.97
Nicolai Tangen's historical trades in CME Group Inc
12 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2020 Q3
|
0.00%
|
$162.54
|
-100% (-638,179)
|
|||
|
2020 Q2
|
1.81%
|
$162.54
|
-14.46% (-107,880)
|
|||
|
2020 Q1
|
2.72%
|
$172.91
|
+1.39% (+10,219)
|
|||
|
2019 Q4
|
3.18%
|
$200.72
|
+4.05% (+28,655)
|
|||
|
2019 Q3
|
3.64%
|
$211.34
|
-24.39% (-228,079)
|
|||
|
2019 Q2
|
4.62%
|
$194.11
|
+54.60% (+330,305)
|
|||
|
2019 Q1
|
3.01%
|
$164.58
|
+21.91% (+108,713)
|
|||
|
2018 Q4
|
4.21%
|
$188.12
|
+9.48% (+42,962)
|
|||
|
2018 Q3
|
3.94%
|
$170.21
|
+16.83% (+65,285)
|
|||
|
2018 Q2
|
3.44%
|
$163.92
|
+9.10% (+32,369)
|
|||
|
2018 Q1
|
3.40%
|
$161.74
|
+22.18% (+64,553)
|
|||
|
2017 Q4
|
3.30%
|
$146.05
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.